感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 USPSTF建议声明：预防性传播感染的行为咨询干预

2020-08-18 美国预防医学工作组 JAMA . 2020 Aug 18;324(7):674-681.

性传播感染

2020年8月，美国预防医学工作组(USPSTF)发布了预防性传播感染的行为咨询干预的建议声明，本文是对2014年版USPSTF建议声明的更新，USPSTF专家组推荐对于所有性传播感染风险增加的性活跃

中文标题：

2020 USPSTF建议声明：预防性传播感染的行为咨询干预

英文标题：

Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement

发布机构：

美国预防医学工作组

发布日期：

2020-08-18

简要介绍：

2020年8月，美国预防医学工作组(USPSTF)发布了预防性传播感染的行为咨询干预的建议声明，本文是对2014年版USPSTF建议声明的更新，USPSTF专家组推荐对于所有性传播感染风险增加的性活跃的青少年和成人进行行为咨询。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 USPSTF建议声明：预防性传播感染的行为咨询干预.pdf)] GetToolGuiderByIdResponse(projectId=1, id=570521c0019560ca, title=2020 USPSTF建议声明：预防性传播感染的行为咨询干预, enTitle=Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement, guiderFrom=JAMA . 2020 Aug 18;324(7):674-681., authorId=0, author=, summary=2020年8月，美国预防医学工作组(USPSTF)发布了预防性传播感染的行为咨询干预的建议声明，本文是对2014年版USPSTF建议声明的更新，USPSTF专家组推荐对于所有性传播感染风险增加的性活跃, cover=https://img.medsci.cn/2020824/1598276385871_2020535.jpg, journalId=0, articlesId=null, associationId=121, associationName=美国预防医学工作组, associationIntro=由预防和循证医学的非联邦专家和初级保健提供者（如内科，儿科医生，家庭医生，妇科/产科医生，护士和健康行为专家）组成的非联邦小组。为初级保健医生和卫生系统提供指导意见和科学证据。, copyright=0, guiderPublishedTime=Tue Aug 18 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，美国预防医学工作组(USPSTF)发布了预防性传播感染的行为咨询干预的建议声明，本文是对2014年版USPSTF建议声明的更新，USPSTF专家组推荐对于所有性传播感染风险增加的性活跃的青少年和成人进行行为咨询。</p> </div> </div> </div>, tagList=[TagDto(tagId=45477, tagName=性传播感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=45477, guiderKeyword=性传播感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2717, appHits=91, showAppHits=0, pcHits=222, showPcHits=2626, likes=0, shares=20, comments=10, approvalStatus=1, publishedTime=Mon Aug 24 22:22:04 CST 2020, publishedTimeString=2020-08-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 24 21:39:59 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 03:20:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 USPSTF建议声明：预防性传播感染的行为咨询干预.pdf)])
2020 USPSTF建议声明：预防性传播感染的行为咨询干预.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=814096, encodeId=b82281409619, content=希望能学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200827/333bd9478e6a401f824dc8dcfdf722ec/6a9099063e5742e980df31dae553c369.jpg, createdBy=4e6b2081946, createdName=zzpivy, createdTime=Thu Aug 27 16:16:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813397, encodeId=ba8881339e08, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51485307767, createdName=1487e56em29暂无昵称, createdTime=Wed Aug 26 11:52:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813050, encodeId=8ec88130507c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Tue Aug 25 15:53:47 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813037, encodeId=123c81303e1d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Tue Aug 25 14:37:07 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812950, encodeId=4c1a812950cb, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Tue Aug 25 08:07:52 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-27 zzpivy

    希望能学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=814096, encodeId=b82281409619, content=希望能学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200827/333bd9478e6a401f824dc8dcfdf722ec/6a9099063e5742e980df31dae553c369.jpg, createdBy=4e6b2081946, createdName=zzpivy, createdTime=Thu Aug 27 16:16:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813397, encodeId=ba8881339e08, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51485307767, createdName=1487e56em29暂无昵称, createdTime=Wed Aug 26 11:52:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813050, encodeId=8ec88130507c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Tue Aug 25 15:53:47 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813037, encodeId=123c81303e1d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Tue Aug 25 14:37:07 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812950, encodeId=4c1a812950cb, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Tue Aug 25 08:07:52 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-26 1487e56em29暂无昵称

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=814096, encodeId=b82281409619, content=希望能学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200827/333bd9478e6a401f824dc8dcfdf722ec/6a9099063e5742e980df31dae553c369.jpg, createdBy=4e6b2081946, createdName=zzpivy, createdTime=Thu Aug 27 16:16:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813397, encodeId=ba8881339e08, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51485307767, createdName=1487e56em29暂无昵称, createdTime=Wed Aug 26 11:52:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813050, encodeId=8ec88130507c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Tue Aug 25 15:53:47 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813037, encodeId=123c81303e1d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Tue Aug 25 14:37:07 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812950, encodeId=4c1a812950cb, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Tue Aug 25 08:07:52 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 ms5000000568257380

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=814096, encodeId=b82281409619, content=希望能学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200827/333bd9478e6a401f824dc8dcfdf722ec/6a9099063e5742e980df31dae553c369.jpg, createdBy=4e6b2081946, createdName=zzpivy, createdTime=Thu Aug 27 16:16:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813397, encodeId=ba8881339e08, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51485307767, createdName=1487e56em29暂无昵称, createdTime=Wed Aug 26 11:52:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813050, encodeId=8ec88130507c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Tue Aug 25 15:53:47 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813037, encodeId=123c81303e1d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Tue Aug 25 14:37:07 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812950, encodeId=4c1a812950cb, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Tue Aug 25 08:07:52 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 ms4000000062793346

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=814096, encodeId=b82281409619, content=希望能学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200827/333bd9478e6a401f824dc8dcfdf722ec/6a9099063e5742e980df31dae553c369.jpg, createdBy=4e6b2081946, createdName=zzpivy, createdTime=Thu Aug 27 16:16:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813397, encodeId=ba8881339e08, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51485307767, createdName=1487e56em29暂无昵称, createdTime=Wed Aug 26 11:52:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813050, encodeId=8ec88130507c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Tue Aug 25 15:53:47 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813037, encodeId=123c81303e1d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Tue Aug 25 14:37:07 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812950, encodeId=4c1a812950cb, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Tue Aug 25 08:07:52 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 sinze

    阅

    0

拓展阅读

2021 WHO指南：有症状的性传播感染的管理

世界卫生组织(WHO,The World Health Organization) · 2021-07-15

2021 AAUS指南：性传播感染的诊断策略

亚洲泌尿系感染和性传播感染协会(AAUS,Asian Association of Urinary Tract Infection and Sexually Transmitted Infection) · 2021-11-17

2022 NICE 指南：减少性传播感染[NG221]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-06-15

性传播感染：2021年疾控中心指南的更新

暂未更新 · 2022-05-01

WHO 为监狱和其他封闭环境中的人员推荐的艾滋病毒、病毒性肝炎和性传播感染预防、诊断、治疗和护理干预措施

世界卫生组织(WHO,The World Health Organization) · 2023-07-10

WHO 国家战略规划指南：卫生部门应对艾滋病毒、病毒性肝炎和性传播感染

世界卫生组织(WHO,The World Health Organization) · 2023-10-23